Biocompatibility of hemodialysis membranes.

Journal of the American Society of Nephrology : JASN
A K Cheung

Abstract

Exposure of blood to hemodialysis membranes results in numerous interactions between the blood elements and the membrane. Transformation and adsorption of plasma proteins (such as complement) and activation of blood cells (such as neutrophils and monocytes) have been studied most extensively by nephrologists in recent years. There is no consensus on the definition of biocompatibility for dialyzer membranes. An operational definition of biocompatibility is the lack of any perturbation of blood constituents. According to this "inert surface" definition, a membrane (for example, one that adsorbs beta 2-microglobulin) can be considered as bioincompatible and yet desirable. Because of the multitude of blood-membrane interactions that may occur during hemodialysis, multiple criteria for biocompatibility needs to be applied in the classification of membranes. A certain bioincompatible phenomenon can be further classified as beneficial or deleterious depending on its biological effects as well as its acute and chronic impacts on the dialysis patient.

Citations

Feb 29, 2000·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·T SudaY Nakashima
Feb 28, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Aikaterini PapayianniDimitrios Memmos
May 9, 2014·The International Journal of Artificial Organs·Patricia Martínez-MiguelSusana López-Ongil
May 1, 1995·Biomaterials·N A HoenichJ Vienken
Aug 30, 1996·Clinica Chimica Acta; International Journal of Clinical Chemistry·H HashimotoK Sumino
Mar 10, 1998·Artificial Organs·E MenegattiL M Sena
Apr 20, 2000·Journal of the American Society of Nephrology : JASN·Alejandro Martín-MaloPedro Aljama
Aug 31, 2000·Journal of the American Society of Nephrology : JASN·Toshio MiyataCharles VAN Ypersele DE Strihou
Dec 15, 2000·Kidney International·J HimmelfarbE McMenamin
Nov 14, 2001·Free Radical Biology & Medicine·J HimmelfarbJ W Heinecke
May 30, 1996·The New England Journal of Medicine·R ThadhaniJ V Bonventre
Jan 1, 1997·Annual Review of Medicine·M PascualN Tolkoff-Rubin
Dec 25, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Hiroyuki OhiNoriko Okada
Feb 12, 2004·Kidney International. Supplement·Clifford J Holmes, Dirk Faict
Feb 10, 2000·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·N A HoenichS J Roberts
Dec 8, 2000·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·J Janatova
Dec 19, 2003·Advances in Renal Replacement Therapy·Thomas Henle, Toshio Miyata
Mar 3, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Yukiko HasuikeYoshihiro Takamitsu
Feb 26, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Sakae OhkawaHiromichi Kumagai
Nov 1, 1996·The Journal of Laboratory and Clinical Medicine·C KarlssonM Braide
Nov 6, 2003·Clinical Chemistry and Laboratory Medicine : CCLM·Toshio MiyataCharles van Ypersele de Strihou
Oct 6, 2004·Seminars in Dialysis·Carrie A Gordon, Jonathan Himmelfarb
Jan 4, 2005·American Journal of Nephrology·Krystyna PawlakMichal Mysliwiec
Dec 10, 1991·Clinical Materials·R Vanholder
Jan 22, 2005·Medicinal Research Reviews·Fulvio FloccariMichele Buemi
Aug 27, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Sabine H A DiepeveenAnton F H Stalenhoef
Apr 1, 1993·Journal of Biomedical Materials Research·S ParzerC Mannhalter
Jul 22, 2005·The Cochrane Database of Systematic Reviews·A M MacleodS Wallace
Jun 11, 2002·Critical Care Clinics·Omaran Abdeen, Ravindra L Mehta
Oct 1, 1991·Alcoholism, Clinical and Experimental Research·J M JonesE Mezey
Nov 2, 2006·Current Opinion in Critical Care·Sean M Bagshaw
Apr 1, 1995·Kidney International·S M Baumgartner-ParzerC Mannhalter
Feb 1, 1996·Kidney International·M PascualJ A Schifferli
May 1, 1994·Kidney International·G Sunder-PlassmannU Klaar
Sep 1, 1993·Kidney International·R M Hakim
Oct 1, 1991·Kidney International·G Sunder-PlassmannP Balcke
Dec 1, 1991·Kidney International·E L Parnes, W B Shapiro
Oct 28, 2014·Langmuir : the ACS Journal of Surfaces and Colloids·Wen ZouChangsheng Zhao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Acta Medica Croatica : C̆asopis Hravatske Akademije Medicinskih Znanosti
P Kes
Contributions to Nephrology
Yoshiaki TakemotoRikio Yoshimura
Seminars in Dialysis
Zhongping HuangWilliam R Clark
© 2021 Meta ULC. All rights reserved